Key terms
About SWAV
Shockwave Medical, Inc. operates as a medical device company, which concentrates on developing and commercializing products intended to transform the way classified cardiovascular disease is treated. The firm offers M5 catheters for treating above-the-knee peripheral artery disease, C2 catheters for treating coronary artery disease, and S4 catheters or treating below-the-knee peripheral artery disease. The company was founded by Daniel Hawkins, John M. Adams, and Todd J. Brinton in 2009 and is headquartered in Santa Clara, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest SWAV news
Apr 09
4:23pm ET
Shockwave Medical Merges with Johnson & Johnson, Retains Key Leader
Apr 08
4:12pm ET
ShockWave Medical data confirm consistent ‘real-world’ outcomes
Apr 08
9:44am ET
Ulta upgraded, Skyworks downgraded: Wall Street’s top analyst calls
Apr 08
8:40am ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: Deciphera Pharmaceuticals (DCPH) and Shockwave Medical (SWAV)
Apr 08
7:41am ET
ShockWave Medical downgraded to Neutral from Buy at CL King
Apr 08
7:37am ET
ShockWave Medical downgraded to Hold from Buy at Needham
Apr 08
6:17am ET
ShockWave Medical downgraded to Equal Weight from Overweight at Morgan Stanley
Apr 08
4:39am ET
ShockWave Medical downgraded to Hold from Buy at Deutsche Bank
Apr 05
4:25pm ET
ShockWave Medical downgraded to Market Perform from Outperform at Leerink
Apr 05
10:37am ET
ShockWave Medical downgraded to Hold from Buy at Canaccord
Apr 05
10:18am ET
ShockWave Medical downgraded to Neutral from Overweight at Piper Sandler
Apr 05
9:38am ET
Krispy Kreme upgraded, Altice USA downgraded: Wall Street’s top analyst calls
Apr 05
9:31am ET
M&A News: Johnson & Johnson (NYSE:JNJ) Enters Into $13.1B Shockwave Medical Deal
Apr 05
9:20am ET
ShockWave Medical downgraded to Hold from Buy at Needham
Apr 05
6:52am ET
Shockwave Medical Set for Acquisition by Johnson & Johnson
Apr 05
6:38am ET
Johnson & Johnson: ShockWave Medical deal to accelerate revenue growth
Apr 05
6:35am ET
Johnson & Johnson sees ShockWave Medical deal dilutive to EPS in FY24/FY25
Apr 05
6:33am ET
Johnson & Johnson to acquire ShockWave Medical for $335.00 per share in cash
Apr 05
6:31am ET
Johnson & Johnson to acquire ShockWave Medical for $335.00 per share in cash
Apr 05
4:50am ET
Analysts Offer Insights on Healthcare Companies: Immunic (IMUX) and Shockwave Medical (SWAV)
Apr 04
7:11pm ET
ShockWave Medical downgraded to Peer Perform from Outperform at Wolfe Research
Apr 02
7:24am ET
ShockWave Medical price target raised to $360 from $290 at Piper Sandler
Apr 02
7:00am ET
Analysts Are Bullish on These Healthcare Stocks: Shockwave Medical (SWAV), Veeva Systems (VEEV)
Mar 29
3:08am ET
Buy Rating Reaffirmed for Shockwave Medical Amid Potential Acquisition Talks and Market-Leading IVL Technology
Mar 27
8:14am ET
Piper says competitive process could materialize for ShockWave
Mar 27
7:39am ET
ShockWave Medical initiated with a Buy at CL King
Mar 26
2:27pm ET
ShockWave Medical up 13% to $324.49 after trading resumes
Mar 26
2:23pm ET
ShockWave Medical trading resumes
Mar 26
2:23pm ET
Johnson & Johnson in talks to acquire Shockwave Medical, WSJ says
Mar 26
2:20pm ET
ShockWave jumps 8% to $311.29 after WSJ report of J&J talks
Mar 26
2:19pm ET
J&J in talks to acquire ShockWave Medical, WSJ reports
Mar 26
2:18pm ET
ShockWave Medical trading halted, volatility trading pause
SWAV Financials
Key terms
Ad Feedback
SWAV Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
SWAV Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
